Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Clinical trial NCT00430677 · TERMINATED

Trial details

NCT number: NCT00430677
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2007-06-01
Primary completion: 2010-09-01
Enrollment: 423

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.